Endomagnetics, the company pioneering the use of magnetic sensors for cancer staging and treatment, has been selected as one of twenty UK companies to take part in the upcoming Future Health Mission 2011 to the USA.

The Mission takes place in San Francisco between January 8th and 14th 2011, and is set up to explore opportunities for the participant companies for growth with potential partners as well as customers, key investors, media and other stakeholders in Silicon Valley. [Read more...]

Endomagnetics Limited, the medical device company that helps surgeons track the spread of breast cancer, has raised £770,000 from a syndicate led by UCL Business PLC and Sussex Place Ventures. The financing coincides with the appointment of Dr Eric Mayes as CEO of this recent spin-out from University College London and builds upon a previous seed round of £350,000 that was secured in June 2009. [Read more...]

In a webcast published today in the cancer journal eCancer, Endomagnetics’ founder Quentin Pankhurst demonstrates the new SentiMag™ in action, and breast cancer surgeon Michael Douek describes his new clinical trial on the use of magnetic tracers for sentinel node detection. [Read more...]